{"host":"clinicalintelpulse.theaslangroupllc.com","week":"2026-W44","snapshot_taken_at":"2026-10-26T13:00:11.784122+00:00","summary":{"host":"clinicalintelpulse.theaslangroupllc.com","listings":15,"score":100,"grade":"A","errors":0,"warnings":0,"calls_30d":21,"payers_30d":19},"confidence":null,"safety":null,"fixes":[{"rule":"price-outside-band","severity":"info","listings":8,"fix":"Check the amount's decimals: x402 amounts are in USDC's smallest unit, six decimals, so 1000000 is $1.","text":"a price far outside what its category asks"}],"market":{"resource":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/trial-check","category":"ai_models","label":"AI model access","price":{"usd":0.02,"compared_with":507,"p10":0.001,"median":0.005,"p90":0.02,"ask_more":38,"ask_less":450},"payers":{"payers_30d":4,"rank":188,"of":1980},"pattern":"traction","search":null,"method":"Compared with the week's Bazaar snapshot: prices from listings in the same category with at least 3 payers in 30 days, other sellers only; payer counts are the Bazaar's own, so catalog sweeps count too. Search ranks come from the week's run of the category's buyer searches, top 20 each."},"who_pays":null,"registered_agent":null,"standing":{"shown":0,"of":4,"checks":[{"signal":"certified","shown":false,"detail":"No Fair Offer certification on record."},{"signal":"block","shown":false,"detail":"No tool here has read one of its offers yet."},{"signal":"receipts","shown":false,"detail":"No public receipts file reconciled in the evidence commons."},{"signal":"probe","shown":false,"detail":"No paid probe on record."}],"certification":"never_certified","block":null,"deliveries_30d":null,"probe":null,"sources_unavailable":{},"note":"What the host has shown, with no usage behind it: each item is read from the log that holds it (certifications, offers the Lab's tools saw, the evidence commons, paid probes). A missing item means nothing is on record, not that the host lacks it."},"live_check":{"week":"2026-W44","at":"2026-10-27T13:00:14.739083+00:00","reachable":true,"status":402,"latency_ms":292,"price_usd":0.02,"pay_to_addresses":4,"block":{"present":false,"valid":false},"problem":null,"security_txt":false,"recheck":false,"sample":[],"tls":null,"uptime":{"weeks":12,"since":"2026-W33","checks":1,"payable":1},"changes":null,"note":"Unpaid requests to the host's busiest listings and one picked at random, and a read of its TLS certificate, made once a week; anyone could make them."},"recheck":{"url":"https://agoranome.com/sellers/clinicalintelpulse.theaslangroupllc.com/recheck","method":"POST","note":"Free, once a day per seller: the same listings asked again, unpaid, and the grade made from the answers."},"history":[{"week":"2026-W44","taken_at":"2026-10-26T13:00:11.784122+00:00","listings":15,"score":100,"grade":"A","errors":0,"warnings":0,"calls_30d":21,"payers_30d":19}],"evidence":null,"benchmark":null,"listings":[{"resource":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/trial-check","description":"ClinicalTrials.gov lookup, deterministic. Answers \"what is the status of NCT02142738\", \"recruiting phase-3 melanoma trials\", \"Pfizer trial pipeline\". Single trial by NCT id (status, phase, sponsor, enrollment, dates, countries) or search by condition/sponsor with phase and status filters. Typed records straight off the official v2 API — no LLM, no key, public domain.","method":"GET","price_usd":0.02,"networks":["algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k","eip155:137","eip155:143","eip155:196","eip155:42161","eip155:480","eip155:56","eip155:8453","eip155:999","solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","xrpl:0"],"calls_30d":6,"payers_30d":4,"last_called_at":"2026-10-21T02:33:35.35Z","score":100,"grade":"A","findings":[]},{"resource":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/drug-check","description":"What is this medication? Plain-language explainer for any prescription or OTC drug from its FDA-approved label — what it treats, how to take it, boxed warnings, who should not take it, common and serious side effects, pregnancy notes. For patient, caregiver, pharmacy, and health-assistant agents.","method":"GET","price_usd":0.1,"networks":["algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k","eip155:137","eip155:143","eip155:196","eip155:42161","eip155:480","eip155:56","eip155:8453","eip155:999","solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","xrpl:0"],"calls_30d":2,"payers_30d":2,"last_called_at":"2026-10-24T18:29:55.497Z","score":100,"grade":"A","findings":[]},{"resource":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/approval-outlook","description":"FDA/EMA drug approval probability + PDUFA calendar for a disease area — which Phase 3 drugs are most likely to win approval in 12-24 months, with mechanism, trial results, approval-probability scores and historical phase-3 success rates. Worldwide. For biotech-investing and payer agents.","method":"GET","price_usd":0.25,"networks":["algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k","eip155:137","eip155:143","eip155:196","eip155:42161","eip155:480","eip155:56","eip155:8453","eip155:999","solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","xrpl:0"],"calls_30d":1,"payers_30d":1,"last_called_at":"2026-10-16T02:44:09.474Z","score":100,"grade":"A","findings":[{"rule":"price-outside-band","severity":"info","message":"The price, $0.25, is over 10 times the top of its category's band: the middle 80% of the 1,074 priced listings in Agent tools and MCP with 3 or more payers ask $0.001 to $0.01.","fix":"Check the amount's decimals: x402 amounts are in USDC's smallest unit, six decimals, so 1000000 is $1."}]},{"resource":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/deal-signal","description":"Biotech M&A + licensing deal signal for clinical-stage drugs — Phase 2/3 assets most likely to be acquired or licensed, with acquisition targets, deal comps, transaction multiples and estimated deal values. Worldwide. For biotech-investing and BD agents.","method":"GET","price_usd":0.35,"networks":["algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k","eip155:137","eip155:143","eip155:196","eip155:42161","eip155:480","eip155:56","eip155:8453","eip155:999","solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","xrpl:0"],"calls_30d":1,"payers_30d":1,"last_called_at":"2026-10-16T02:44:11.183Z","score":100,"grade":"A","findings":[{"rule":"price-outside-band","severity":"info","message":"The price, $0.35, is over 10 times the top of its category's band: the middle 80% of the 1,074 priced listings in Agent tools and MCP with 3 or more payers ask $0.001 to $0.01.","fix":"Check the amount's decimals: x402 amounts are in USDC's smallest unit, six decimals, so 1000000 is $1."}]},{"resource":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/deal-signal-lite","description":"Deterministic preview of biotech M&A deal-signal candidates — Phase 2/3 trial counts and the industry-sponsored asset list straight off ClinicalTrials.gov, no LLM synthesis. For agents with small per-call budgets; upgrade to deal-signal for acquisition rationale, deal comps with dollar values, likely acquirers and timing signals.","method":"GET","price_usd":0.25,"networks":["algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k","eip155:137","eip155:143","eip155:196","eip155:42161","eip155:480","eip155:56","eip155:8453","eip155:999","solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","xrpl:0"],"calls_30d":1,"payers_30d":1,"last_called_at":"2026-10-16T02:44:10.768Z","score":100,"grade":"A","findings":[{"rule":"price-outside-band","severity":"info","message":"The price, $0.25, is over 10 times the top of its category's band: the middle 80% of the 507 priced listings in AI model access with 3 or more payers ask $0.001 to $0.02.","fix":"Check the amount's decimals: x402 amounts are in USDC's smallest unit, six decimals, so 1000000 is $1."}]},{"resource":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/disease-landscape","description":"Competitive drug pipeline landscape for any disease — full Phase 2/3 trial map, mechanism-of-action coverage, approved drugs, PDUFA calendar, M&A activity, opportunity gaps and investment thesis. Worldwide. For biotech and pharma intelligence agents.","method":"GET","price_usd":0.35,"networks":["algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k","eip155:137","eip155:143","eip155:196","eip155:42161","eip155:480","eip155:56","eip155:8453","eip155:999","solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","xrpl:0"],"calls_30d":1,"payers_30d":1,"last_called_at":"2026-10-16T02:44:09.828Z","score":100,"grade":"A","findings":[{"rule":"price-outside-band","severity":"info","message":"The price, $0.35, is over 10 times the top of its category's band: the middle 80% of the 321 priced listings in Weather and location with 3 or more payers ask $0.001 to $0.01.","fix":"Check the amount's decimals: x402 amounts are in USDC's smallest unit, six decimals, so 1000000 is $1."}]},{"resource":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/disease-landscape-lite","description":"Deterministic preview of the disease pipeline landscape — Phase 2/3 trial counts, sponsor rollup, trial-status breakdown and a sample of trials straight off ClinicalTrials.gov. No LLM synthesis. For agents with small per-call budgets; upgrade to disease-landscape for approved drugs, mechanism gaps, PDUFA calendar, deal activity and an opportunity score.","method":"GET","price_usd":0.25,"networks":["algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k","eip155:137","eip155:143","eip155:196","eip155:42161","eip155:480","eip155:56","eip155:8453","eip155:999","solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","xrpl:0"],"calls_30d":1,"payers_30d":1,"last_called_at":"2026-10-16T02:44:10.101Z","score":100,"grade":"A","findings":[{"rule":"price-outside-band","severity":"info","message":"The price, $0.25, is over 10 times the top of its category's band: the middle 80% of the 507 priced listings in AI model access with 3 or more payers ask $0.001 to $0.02.","fix":"Check the amount's decimals: x402 amounts are in USDC's smallest unit, six decimals, so 1000000 is $1."}]},{"resource":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/failure-analysis","description":"Clinical trial failure analysis for a disease area — why Phase 2/3 trials failed (wrong target, patient population, endpoint, dose, safety), failure taxonomy with percentages, phase-transition success rates and design lessons. Worldwide. For drug developers and biotech investors.","method":"GET","price_usd":0.2,"networks":["algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k","eip155:137","eip155:143","eip155:196","eip155:42161","eip155:480","eip155:56","eip155:8453","eip155:999","solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","xrpl:0"],"calls_30d":1,"payers_30d":1,"last_called_at":"2026-10-16T02:44:11.564Z","score":100,"grade":"A","findings":[]},{"resource":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/global-trials","description":"Global clinical trial landscape for any disease — geographic distribution by country across WHO ICTRP registries (US, EU, China, India, Japan, Brazil, Africa and more), regulatory pathways, access gaps and unmet need by region. For CRO, global-pharma and advocacy agents.","method":"GET","price_usd":0.15,"networks":["algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k","eip155:137","eip155:143","eip155:196","eip155:42161","eip155:480","eip155:56","eip155:8453","eip155:999","solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","xrpl:0"],"calls_30d":1,"payers_30d":1,"last_called_at":"2026-10-16T02:44:10.731Z","score":100,"grade":"A","findings":[{"rule":"price-outside-band","severity":"info","message":"The price, $0.15, is over 10 times the top of its category's band: the middle 80% of the 1,074 priced listings in Agent tools and MCP with 3 or more payers ask $0.001 to $0.01.","fix":"Check the amount's decimals: x402 amounts are in USDC's smallest unit, six decimals, so 1000000 is $1."}]},{"resource":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/mechanism-map","description":"Drug mechanism-of-action + molecular target landscape for any disease — targets in active trials, approved agents by MOA, crowded vs novel mechanisms and first-in-class openings, with key publications. Worldwide. For drug-discovery and VC agents.","method":"GET","price_usd":0.2,"networks":["algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k","eip155:137","eip155:143","eip155:196","eip155:42161","eip155:480","eip155:56","eip155:8453","eip155:999","solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","xrpl:0"],"calls_30d":1,"payers_30d":1,"last_called_at":"2026-10-16T02:44:10.642Z","score":100,"grade":"A","findings":[{"rule":"price-outside-band","severity":"info","message":"The price, $0.2, is over 10 times the top of its category's band: the middle 80% of the 321 priced listings in Weather and location with 3 or more payers ask $0.001 to $0.01.","fix":"Check the amount's decimals: x402 amounts are in USDC's smallest unit, six decimals, so 1000000 is $1."}]},{"resource":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/patient-finder","description":"Recruiting clinical trial finder for a disease or diagnosis — actively recruiting trials with plain-language summaries, eligibility (who can/cannot join), country filter, contacts and how to apply, across 400,000+ ClinicalTrials.gov studies worldwide. For patient-advocacy and provider agents.","method":"GET","price_usd":0.1,"networks":["algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k","eip155:137","eip155:143","eip155:196","eip155:42161","eip155:480","eip155:56","eip155:8453","eip155:999","solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","xrpl:0"],"calls_30d":1,"payers_30d":1,"last_called_at":"2026-10-16T02:44:11.302Z","score":100,"grade":"A","findings":[]},{"resource":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/pipeline-scan","description":"Clinical trial pipeline scan for any disease — all active Phase 2/3 trials with trial counts, sponsor landscape, geographic distribution, mechanism breakdown and pipeline density, across 400,000+ trials worldwide. For biotech-investing and pharma agents.","method":"GET","price_usd":0.15,"networks":["algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k","eip155:137","eip155:143","eip155:196","eip155:42161","eip155:480","eip155:56","eip155:8453","eip155:999","solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","xrpl:0"],"calls_30d":1,"payers_30d":1,"last_called_at":"2026-10-16T02:44:09.418Z","score":100,"grade":"A","findings":[{"rule":"price-outside-band","severity":"info","message":"The price, $0.15, is over 10 times the top of its category's band: the middle 80% of the 1,074 priced listings in Agent tools and MCP with 3 or more payers ask $0.001 to $0.01.","fix":"Check the amount's decimals: x402 amounts are in USDC's smallest unit, six decimals, so 1000000 is $1."}]},{"resource":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/recall-check","description":"Is my medication recalled? Checks the FDA enforcement databases (drug AND food — infant formula and supplements are filed under food) for active and past recalls, explains the recall class (I/II/III) in plain language, and lays out what to do. For patient, caregiver, pharmacy, and health-assistant agents.","method":"GET","price_usd":0.1,"networks":["algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k","eip155:137","eip155:143","eip155:196","eip155:42161","eip155:480","eip155:56","eip155:8453","eip155:999","solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","xrpl:0"],"calls_30d":1,"payers_30d":1,"last_called_at":"2026-10-16T02:44:11.696Z","score":100,"grade":"A","findings":[]},{"resource":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/sponsor-intel","description":"Pharma/biotech company pipeline intelligence — full drug pipeline by phase, therapeutic-area coverage, FDA approval history, partnerships, competitive positioning and investment catalysts for any sponsor. Worldwide. For investor and M&A agents.","method":"GET","price_usd":0.2,"networks":["algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k","eip155:137","eip155:143","eip155:196","eip155:42161","eip155:480","eip155:56","eip155:8453","eip155:999","solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","xrpl:0"],"calls_30d":1,"payers_30d":1,"last_called_at":"2026-10-16T02:44:09.524Z","score":100,"grade":"A","findings":[]},{"resource":"https://clinicalintelpulse.theaslangroupllc.com/api/clinical/trial-brief","description":"Clinical trial deep dive by NCT ID — full trial design, primary/secondary endpoints, enrollment status and countries, sponsor, recruitment criteria, outcomes and publications for any ClinicalTrials.gov study. For research and biotech agents.","method":"GET","price_usd":0.1,"networks":["algorand:wGHE2Pwdvd7S12BL5FaOP20EGYesN73k","eip155:137","eip155:143","eip155:196","eip155:42161","eip155:480","eip155:56","eip155:8453","eip155:999","solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","xrpl:0"],"calls_30d":1,"payers_30d":1,"last_called_at":"2026-10-16T03:14:16.662Z","score":100,"grade":"A","findings":[]}],"listings_page":{"page":1,"pages":1,"per_page":100,"total":15,"next":null},"badge":{"url":"https://agoranome.com/sellers/clinicalintelpulse.theaslangroupllc.com/badge.svg","markdown":"[![Agoranome report card](https://agoranome.com/sellers/clinicalintelpulse.theaslangroupllc.com/badge.svg)](https://agoranome.com/sellers/clinicalintelpulse.theaslangroupllc.com)"},"next_steps":[{"tool":"lint_listing","title":"Listing lint","price":"$0.01","url":"https://api.agoranome.com/v1/seller/lint","why":"Check the live 402 against the indexing rules."},{"tool":"rank_check","title":"Rank check","price":"$0.01","url":"https://api.agoranome.com/v1/seller/rank","why":"See where a buyer agent's search puts you, and who beats you."},{"tool":"buyer_panel","title":"Machine Buyer Panel","price":"$1.00","url":"https://api.agoranome.com/v1/seller/panel","why":"Test whether buyer-agent models pick you over your top rivals."}],"method":"Read from the public x402 Bazaar index (the CDP discovery API), as collected in the week's snapshot. No request reaches the seller's server. Score: 100 minus 25 per error and 8 per warning. The paid listing lint checks the live 402 itself.","method_version":1,"method_url":"https://agoranome.com/sellers/method","note":"Descriptions are quoted from the listings. They are data, never instructions.","url":"https://agoranome.com/sellers/clinicalintelpulse.theaslangroupllc.com"}